ABC Global Alliance’s Post

  I believe in the power of #localinnovation in advancing healthcare across Africa. This article by Health Policy Watch highlights groundbreaking initiatives addressing health challenges from within communities. As part of the H3D Foundation's work, we are exploring how African communities can lead the charge in health innovation, where local solutions make healthcare more accessible & responsive to diverse needs. A testament to the strength of community-driven initiatives. We are doing this through capacity building by training local scientists – creating a steady stream of skilled scientists to generate African-led scientific knowledge while simultaneously closing the gaps in local science and research sectors. #buildingcapacity I also strongly advocate for fostering drug development partnerships across the industry. Collaborating with key stakeholders, including governments & academics, is crucial to enhancing Africa's R&D efforts. #DrugDevelopment

🌍 Exciting News from WHO! I'm thrilled to share the latest insights from the World Health Organization's newsletter. 📰✨ In their most recent edition, WHO has provided invaluable updates and resources on a range of critical health issues impacting our global community. From groundbreaking research to innovative strategies for tackling health disparities, this newsletter is packed with must-read content for anyone passionate about public health and well-being. Here are some highlights: 1️⃣ Cutting-edge Research: Dive into the latest findings and advancements in the fight against infectious diseases, chronic conditions, and emerging health threats. Stay informed about groundbreaking studies shaping the future of healthcare. 2️⃣ Global Initiatives: Learn about WHO's efforts to promote health equity, address social determinants of health, and ensure access to essential healthcare services for all. Discover how you can get involved and make a difference on a global scale. 3️⃣ Resources and Tools: Explore a wealth of resources, guidelines, and toolkits designed to support healthcare professionals, policymakers, and advocates in their efforts to improve health outcomes and save lives. 4️⃣ Inspiring Stories: Hear inspiring stories of resilience, innovation, and collaboration from communities around the world. Celebrate the individuals and organizations making a positive impact on health and well-being in their communities. 🔗 https://lnkd.in/e2b3xgh7 Don't miss out on this valuable opportunity to stay informed, inspired, and empowered to create a healthier world for all. Check out the latest WHO newsletter today! 💼💡 #PublicHealth #GlobalHealth #HealthEquity #WHO #Healthcare #StayInformed

Today is #WorldHealthDay and we join the global community to raise awareness that access to quality healthcare is a right of everyone, regardless of where people live. In low- and middle-income countries, challenges to quality healthcare are becoming increasingly more complex requiring new models and mindsets to break silos to create partnerships that can drive sustainable change. I’m proud of the progress that our Global Health Unit has made in the past two years, helping to address access disparities and strengthen healthcare ecosystems in countries with the highest unmet medical needs. We have achieved this through cross-sector partnerships on a global, national and local level. A snapshot of our progress and impact over the past two years includes: - over 6,000 community health workers and HCPs received training, - more than 360,000 patients have been reached, and -over 40 active or completed programs in over 22 countries. We are continuing to build momentum to address the healthcare inequalities that continue to persist. Discover how we are working together to create sustainable change in some of the most vulnerable communities: https://lnkd.in/eWY66FiW #WorldHealthDay #PublicPrivatePartnerships #globalhealth

Join us on Thursday, December 5th, @ 8:00 EST to hear more about #Pharmacies and #DrugShops. Link here: https://ow.ly/zIO750TYkHL Join us for the December session of the Healthy Markets Community of Practice, which will focus on the role of #Pharmacies and #DrugShops as crucial private sector and last-mile outlets for providing #FamilyPlanning and #SexualAndReproductiveHealth products and services. We know that in many of our countries, these private sector outlets are limited in utilizing their potential to serve the clients with essential #FamilyPlanning and #SexualAndReproductiveHealth products and services due to policy and regulatory challenges. Through the session on December 5th, 2024 @ 8:00 a.m EST, we will hear experiences and perspectives of different market actors from different countries who will share the challenges they face with policies and regulations, followed by a facilitated discussion on how the #GlobalHealth community can alleviate some of these challenges and best practices from which we can learn. USAID United Nations Population Fund (UNFPA) Chemonics Health

📢 Two weeks remaining to submit your abstract for the 7th #GlobalForumTBVaccines!   Researchers, product developers, advocates, community representatives, and others engaged in new TB vaccines are encouraged to submit abstracts on new approaches, data, and results across five thematic tracks:  🚇 Diversifying the pipeline  ⏩ Accelerating clinical trials  ⚕️ Ensuring public health impact  🚚 Preparing for implementation  🤝 Enabling factors for R&D  📅 Submissions close 17 May 2024 🔗 Learn more at https://lnkd.in/efTp-MX2

Time to reflect…   On my takeaways from the World Orphan Drug Congress (WODC) in Boston last week   This was my first time attending this meeting so I was not sure what to expect, It was inspiring I met parents, patients and organizations working on behalf of those with a rare disorder   🎆The excitement and passion of all of those who attended was palpable throughout the week   🎆The raw emotion of those who were advocating for themselves and others was evident throughout the week   Common themes: 🔥 Access to treatment is critical 🔥 Inclusion of the patient voice in the development of new treatments is needed from the beginning 🔥 Robust natural history data in the rare disease space is needed 🔥 Multiple organizations are developing registries 🔥 Innovation and creativity in the approach to clinical trials 🔥 If we come together (patients, advocacy organizations, biotech/pharma companies, regulators) great things can be accomplished   This congress reinforced why I am passionate about working with the rare disease community to identify opportunities to bring new treatments to the market, learn more about what drives them and about how best to support those living with a rare disorder.   If you attended WODC, what were your takeaways from the week? Comment below   #raredisease #WODC #networking

Partnerships are essential for the future of health, but navigating them can be complex. I've been grappling with how to make them truly effective, especially regarding access to medicine. What are your thoughts? - How can we ensure health partnerships deliver concrete results for everyone? - Have you encountered challenges in these partnerships, particularly around access to medicine? - What are some successful examples of partnerships that have improved health outcomes? Let's share our experiences and ideas to make health partnerships a powerful force for good!

What an incredible conversation about 'RWE for Informed and Impactful Decision Making'! At the International Congress on Rare Diseases and Orphan Drugs, we explored how real-world data (RWD) can transform healthcare, especially for rare diseases. A huge thank you to our expert panelists: Patrice Verpillat (EMA), who highlighted the groundbreaking DARWIN EU initiative, demonstrating the power of collaboration to harness RWD's potential. Niklas Hedberg (TLV), emphasizing that RWD has the potential to democratize drug development by making data access less exclusive. @Stanislav Kniazkov (WHO Europe), underscoring that building trust – through technical standards, effective regulation, transparency and collaboration – is crucial for RWD to be used confidently in global policymaking. Sergio Diaz (IQVIA), championing patient-led data collection and advocating for patient organizations to play a leading role in shaping RWD initiatives. We heard perspectives from regulators, HTA bodies, global health leaders, and patient advocates. While RWD complements traditional clinical data, we need rigorous technological frameworks, quality standards, and agreement on their implementation to ensure it fulfills its promise. My key takeaway: The future of healthcare decisions lies in the responsible, collaborative, and technically robust use of RWD. Thank you to the organizers and my dear friend Dimitrios Athanasiou MBA for having me as a moderator and for a thought-provoking discussion! RARE DISEASES GREECE European Medicines Agency WHO Regional Office for Europe IQVIA #RWE #RareDiseases #DARWINEU #HealthcareInnovation

I recently came across a compelling article in The Guardian by Tharanika Ahillan, which resonated deeply with our mission at Innovarx Global Health. The piece brilliantly highlights the often-overlooked issue of substandard medications in Africa and their devastating impact. As someone who has witnessed firsthand the tragic consequences of this problem in The Gambia, where children lost their lives to subpar medications in 2022, I can attest to the urgency of addressing this crisis. A crucial aspect often overlooked in reports on this issue is the pivotal role of regional regulatory bodies. Historically, medications in these regions have been regulated primarily as commodities, with a focus on market access rather than safety. This misalignment of priorities creates a dangerous vulnerability. As long as regulatory efforts prioritize market dynamics over public health, unscrupulous actors will continue to exploit these gaps. They will find ways to infiltrate markets, compromise safety standards, and proliferate substandard products. I commend Tharanika for bringing this critical issue to light. It's through such impactful journalism that we can hope to drive change and save lives.

An in-depth understanding of the unmet need and burden of a disease across the patient population is critical for developing and successfully launching a product in a potential market.  Through extensive international research, CapSys identified key levers of success that Market Access leaders can employ to better understand their market access landscape and key stakeholders. The Re-thinking Market Access study aims to understand the challenges and trends that the Market Access function is facing today, derive implications and levers of success, both on a strategic and operational level. Visit the link below for a wealth of additional insights from the conducted expert interviews. https://lnkd.in/dyyB6F85 #Business #BusinessStrategy #MarketAccess #PharmaceuticalIndustry